Free Trial
LON:DCTA

Directa Plus (DCTA) Share Price, News & Analysis

Directa Plus logo
GBX 19.50 -0.90 (-4.41%)
As of 11:20 AM Eastern

About Directa Plus Stock (LON:DCTA)

Key Stats

Today's Range
18
19.50
50-Day Range
6.45
20.40
52-Week Range
5.50
21
Volume
272,593 shs
Average Volume
87,951 shs
Market Capitalization
£26.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Directa Plus has a unique and patented, chemical-free production process of pristine graphene nanoplatelets (GNPs), tailored to our partners’ and customers’ requirements. The manufacturing model is flexible and scalable. We have a pioneering vision of the applications of G+® Graphene Plus in different industrial sectors. The markets where G+® is already at a commercial stage are: textile, environment, composites, elastomers and tires, battery and paints. Directa Plus launched the Graphehe Factory in 2010, an industrial plant able to produce up to 30 tonnes of different grades of G+® depending on the market’s needs. In 2017, we established an Advanced Development Area (ADA) composed of different laboratories to test and certify the performance quality of all our products. ADA team provides technical support to our clients and partners.

Receive DCTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Directa Plus and its competitors with MarketBeat's FREE daily newsletter.

DCTA Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Directa Plus Share Chat
Directa Plus (DCTA)
See More Headlines

DCTA Stock Analysis - Frequently Asked Questions

Directa Plus' stock was trading at GBX 6.50 at the beginning of 2025. Since then, DCTA stock has increased by 200.0% and is now trading at GBX 19.50.
View the best growth stocks for 2025 here
.

Shares of DCTA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Directa Plus investors own include Indivior (INDV), Advanced Accelerator Applications (AAAP), Editas Medicine (EDIT), MGT Capital Investments (MGTI), Biglari (BH), Bigblu Broadband (BBB) and Futura Medical (FUM).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
LON:DCTA
CIK
N/A
Fax
N/A
Employees
187
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
15.31
P/E Growth
N/A
Net Income
-£9.74 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£20.29 million
Cash Flow
GBX 2.60 per share
Price / Cash Flow
7.51
Book Value
GBX 8.89 per share
Price / Book
2.19

Miscellaneous

Free Float
N/A
Market Cap
£26.23 million
Optionable
Not Optionable
Beta
0.74
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (LON:DCTA) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners